As publisher, Wolters Kluwer will focus on enhancing JBJS’ reputation and influence and expanding its readership globally to further its mission of providing evidence-based research to enhance the quality of orthopaedic care. Global access to the JBJS portfolio will be expanded via its inclusion in various Ovid® collections.
An independent, non-profit publisher, JBJS produces print and online journals and learning products. The flagship journal, The Journal of Bone & Joint Surgery, traces its origins back to the 1889 Transactions of the American Orthopedic Association, and is the gold standard in peer-reviewed scientific information in orthopaedics. JBJS is also an accredited provider of Continuing Medical Education (CME) and produces online CME activities.
“We look forward to working with Wolters Kluwer to further increase the reach of the top quality orthopaedic information published in our portfolio of JBJS journals as well as potential new information products. Both organizations will realize exceptional benefits from this partnership,” said Paul Sandford, JBJS Chief Executive Officer.
“Indispensable reading for orthopaedic surgeons worldwide, The Journal of Bone & Joint Surgery will become one of the flagship titles in our orthopaedic surgery portfolio and an essential title in our leading general surgery journal list,” said Jayne Marks, Vice President of Global Publishing for Wolters Kluwer, Health Learning Research & Practice. “We are proud to have this opportunity to leverage our full expertise in medical and healthcare publishing solutions to maintain each journal’s unique identity and brand as we focus on enhancing the portfolio’s impact on orthopaedic care globally.”
###
About Wolters KluwerWolters Kluwer is a global leader in professional information services. Professionals in the areas of legal, business, tax, accounting, finance, audit, risk, compliance and healthcare rely on Wolters Kluwer's market leading information-enabled tools and software solutions to manage their business efficiently, deliver results to their clients, and succeed in an ever more dynamic world.
Wolters Kluwer reported 2014 annual revenues of €3.7 billion. The group serves customers in over 170 countries, and employs over 19,000 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands. Wolters Kluwer shares are listed on NYSE Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices. Wolters Kluwer has a sponsored Level 1 American Depositary Receipt program. The ADRs are traded on the over-the-counter market in the U.S. (WTKWY).
For more information about our products and organization, visit www.wolterskluwerhealth.com, follow @WKHealth or @Wolters_Kluwer on Twitter, like us on Facebook, follow us on LinkedIn, or follow WoltersKluwerComms on YouTube.
About JBJS JBJS, Inc., is a not-for-profit publisher specializing in orthopaedic information. It publishes The Journal of Bone & Joint Surgery, which has been the most valued source of information for orthopaedic surgeons and researchers for over 125 years and is the gold standard in peer-reviewed scientific information in the field – a core journal and essential reading for orthopaedic surgeons worldwide. Other publications include JBJS Reviews, JBJS Case Connector and JBJS Essential Surgical Techniques, along with CME and professional development products. Twitter: @jbjs.
RSS